subject: Heilongjiang Pharmaceutical Industry, "low Carbon" Structural Adjustments In [print this page] Hao Weizhe that low-carbon economy less resource consumption than the product itself, but also the product of creativity, research, investment, production, sales, service and recycling process must contain a series of low-carbon system. Currently, many multinational pharmaceutical companies have begun to act, to the Chinese enterprises to promote their "low carbon" technology and "low carbon" products, to seek the "low-carbon economy" big Western business. However, in the low-carbon technologies and products as the core of the new round of national competitive race in the lead who, not only will be leading the trend of world economic development but also in technology transfer, standards development, on the right of access to lead, as an international the biggest winner in the market profits.
Heilongjiang Pharmaceutical Industry, "low Carbon" Structural Adjustments In
